EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Practical Application of Evidence-Based Dietary Therapy in Inflammatory Bowel Disease: The DELECTABLE Program

Gina L Trakman iD, Erin E Russell, Amy L Hamilton iD, Amy Wilson-O'Brien, Emily Thompson iD, Natalie Simmance iD, Ola Niewiadomski, Michael A Kamm

Nutrients · 2025

DOI: 10.3390/nu17091592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Gina L Trakman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, St Vincent's Hospital, Melbourne 3065, Australia. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gastroenterology Society of Australia (GESA), The Yencken Family, Australasian Gastro Intestinal Research Foundation (AGIRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Exclusive Enteral Nutrition (EEN) and the Crohn’s Disease Exclusion Diet (CDED) have been shown to induce remission in Crohn’s disease. Low-sulphur, plant-based diets are being explored for ulcerative colitis, and wholefood, low-additive approaches are emerging as significant. Although Inflammatory Bowel Disease (IBD) patients modify their diet, evidence for tolerability and benefit outside clinical trials is limited. The DELECTABLE program aimed to assess satisfaction, adherence, and efficacy of dietary therapies as part of IBD care.

Methods

In this dietitian-led, open-label, prospective study, patients with Crohn’s disease were offered the CDED or a whole-food, additive-free diet (WFD), and patients with ulcerative colitis were offered a low-sulphur, plant-based diet (UCD) or WFD. Primary outcomes were 12-week diet satisfaction (modified DSAT-28) and diet adherence, including food additive intake. Secondary outcomes were quality of life (QoL) (IBDQ-9), disease activity (CDAI for Crohn’s disease, partial Mayo score for ulcerative colitis), and biochemical markers (CRP, faecal calprotectin). Analyses were conducted within, rather than between, diet arms due to the non-random nature of the study. Diet adherence and disease activity change across time points (baseline, week 6, week 12) were assessed using repeated measures ANOVA or Friedman’s test, with pairwise paired t-test or Wilcoxon Signed-Rank test. Diet satisfaction and quality of life changes across time (baseline/week 1, week 12) were assessed using a paired t-test or Wilcoxon Signed-Rank test.

Results

Of 165 referrals, 76 patients enrolled, with 64 completing the 12-week program (CDED: n = 15, WFD: n = 42, UCD: n = 7). Diet satisfaction was initially high and remained stable over time on CDED (p = 0.212) and improved on WFD (p = 0.03). Patient- and dietitian-rated adherence was high at baseline and did not significantly decrease on any diet arm (p > 0.349). Food additive intake decreased on WFD (p = 0.009). QoL improved on CDED and WFD (p < 0.001). CRP, calprotectin, and CDAI were reduced on CDED (p < 0.045), and CDAI and partial Mayo were reduced on WFD (p < 0.027).

Conclusions

Well-balanced therapeutic diets are feasible and well-accepted by patients with IBD, with a promising impact on disease activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesHumansMaleFemaleAdultProspective StudiesMiddle AgedQuality of LifeTreatment OutcomePatient CompliancePatient SatisfactionEvidence-Based MedicineYoung AdultDiet

Stichwörter der Autor:innen

Mediterranean dietcomplianceemulsifierinflammationtolerance

Autor:innen und Institutionen

  • Department of Gastroenterology, St Vincent's Hospital, Melbourne 3065, Australia.
  • Department of Medicine, The University of Melbourne, Melbourne 3065, Australia.
  • Discipline of Food, Nutrition and Dietetics, Department of Sport, Exercise and Nutrition Science, La Trobe University, Melbourne 3086, Australia.
  • Department of Nutrition and Dietetics, St Vincent's Hospital, Melbourne 3065, Australia.

ORCID-Profile: Gina L Trakman, Amy L Hamilton, Emily Thompson, Natalie Simmance

Förderung

  • Gastroenterology Society of Australia (GESA)
  • The Yencken Family
  • Australasian Gastro Intestinal Research Foundation (AGIRF)
  • Australasian Gastrointestinal Research Foundation (AGIRF)

Zitieren

APA

Trakman, G. L., Russell, E. E., Hamilton, A. L., Wilson-O'Brien, A., Thompson, E., Simmance, N., Niewiadomski, O., & Kamm, M. A. (2025). Practical Application of Evidence-Based Dietary Therapy in Inflammatory Bowel Disease: The DELECTABLE Program. Nutrients. https://doi.org/10.3390/nu17091592

Vancouver

Trakman GL, Russell EE, Hamilton AL, Wilson-O'Brien A, Thompson E, Simmance N, et al. Practical Application of Evidence-Based Dietary Therapy in Inflammatory Bowel Disease: The DELECTABLE Program. Nutrients. 2025. doi:10.3390/nu17091592

BibTeX
@article{Trakman2025,
  author = {Trakman, Gina L and Russell, Erin E and Hamilton, Amy L and Wilson-O'Brien, Amy and Thompson, Emily and Simmance, Natalie and Niewiadomski, Ola and Kamm, Michael A},
  title = {Practical Application of Evidence-Based Dietary Therapy in Inflammatory Bowel Disease: The DELECTABLE Program},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17091592}
}
Kostenlos starten →